SCHEMBL5533574

SCHEMBL5533574

Cc1ccc(C)c(Nc2ncc(CCC(C)N(C)C)c(N)n2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
PKM P14618 1/20 0.43
DHFR P00374 3/20 0.39
SRC P12931 1/20 0.37
SYK P43405 1/20 0.37
LMNA P02545 1/20 0.37
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33
MAPK3 P27361 3/20 0.33
POLB P06746 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MITF O75030 1/20 0.33
TP53 P04637 1/20 0.33
MAPT P10636 1/20 0.33
BLM P54132 1/20 0.33
RAPGEF4 Q8WZA2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5522571 0.91 RAB9A (0.41) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL5529329 0.87 HTT (0.45) NPC1RAB9ASMN1; SMN2PKMLMNA
SCHEMBL5527171 0.84 L3MBTL1 (0.47) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL5524909 0.84 RAB9A (0.43) MEN1KMT2ANPC1RAB9ADHFR
SCHEMBL2115678 0.84 NPC1 (0.46) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL5525987 0.83 NPC1 (0.41) NPC1RAB9ASMN1; SMN2PKMDHFR
SCHEMBL2113275 0.82 MEN1 (0.45) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL2114722 0.81 MEN1 (0.44) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL5529511 0.81 TNK2 (0.35) KMT2ADHFRMAPT
SCHEMBL5519624 0.80 DHFR (0.39) NPC1RAB9ADHFRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-12-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293525-A1 2-ANILINO-4-AMINOALKYLENEAMINOPYRIMIDINES PRKCA, PRKCH, PRKCG MEN1 4847/4885KMT2A 1889/4885NPC1 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.